These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37870153)

  • 1. Percutaneous Intratumoral Immunoadjuvant Gel Increases the Abscopal Effect of Cryoablation for Checkpoint Inhibitor Resistant Cancer.
    Som A; Rosenboom JG; Wehrenberg-Klee E; Chandler A; Ndakwah G; Chen E; Suggs J; Morimoto J; Kim J; Mustafa AR; Marcos-Vidal A; Fintelmann FJ; Basu A; Langer R; Traverso G; Mahmood U
    Adv Healthc Mater; 2024 Mar; 13(6):e2301848. PubMed ID: 37870153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging cryoablation and checkpoint inhibitors for high-risk triple negative breast cancer.
    Sardela de Miranda F; Castro M; Remmert N; Singh SP; Layeequr Rahman R; Melkus MW
    Front Immunol; 2023; 14():1258873. PubMed ID: 37860001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abscopal Effect Following Cryoablation in a Patient with Metastatic Breast Cancer.
    Kaplan JL; Turker I; Chumsri S; Gabriel E
    Front Biosci (Schol Ed); 2023 Jan; 15(1):2. PubMed ID: 36959110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the use of cryoablation and immunotherapy for breast cancer.
    Olagunju A; Forsman T; Ward RC
    Front Immunol; 2022; 13():1026475. PubMed ID: 36389815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryoablation triggers type I interferon-dependent antitumor immunity and potentiates immunotherapy efficacy in lung cancer.
    Gu C; Wang X; Wang K; Xie F; Chen L; Ji H; Sun J
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38272564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional tumor cell-intrinsic STING, not host STING, drives local and systemic antitumor immunity and therapy efficacy following cryoablation.
    Alshebremi M; Tomchuck SL; Myers JT; Kingsley DT; Eid S; Abiff M; Bonner M; Saab ST; Choi SH; Huang AY
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37553183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photothermal-Activatable Fe
    Ge R; Liu C; Zhang X; Wang W; Li B; Liu J; Liu Y; Sun H; Zhang D; Hou Y; Zhang H; Yang B
    ACS Appl Mater Interfaces; 2018 Jun; 10(24):20342-20355. PubMed ID: 29878757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes.
    Takada M; Toi M
    Int J Clin Oncol; 2019 Jun; 24(6):608-613. PubMed ID: 30982153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of cryoablation: An abscopal effect.
    Chen J; Qian W; Mu F; Niu L; Du D; Xu K
    Cryobiology; 2020 Dec; 97():1-4. PubMed ID: 32097610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Infiltrating Lymphocytes (TILs) as a Biomarker of Abscopal Effect of Cryoablation in Breast Cancer: A Pilot Study.
    Khan SY; Melkus MW; Rasha F; Castro M; Chu V; Brandi L; Khan H; Gill HS; Pruitt K; Layeequr Rahman R
    Ann Surg Oncol; 2022 May; 29(5):2914-2925. PubMed ID: 35094188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous ablative cryoimmunotherapy for micrometastaic abscopal effect: No complications.
    Soule E; Bandyk M; Matteo J
    Cryobiology; 2018 Jun; 82():22-26. PubMed ID: 29680230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous-cancer-cryoablation-mediated nanovaccine augments systematic immunotherapy.
    Yu Z; Wang D; Qi Y; Liu J; Zhou T; Rao W; Hu K
    Mater Horiz; 2023 May; 10(5):1661-1677. PubMed ID: 36880811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryoablation and Immunotherapy for Breast Cancer: Overview and Rationale for Combined Therapy.
    Regen-Tuero HC; Ward RC; Sikov WM; Littrup PJ
    Radiol Imaging Cancer; 2021 Mar; 3(2):e200134. PubMed ID: 33817653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal Irreversible Electroporation Combined with Nano-Enabled Immunomodulatory to Boost Systemic Antitumor Immunity.
    Peng W; Cao Y; Zhang Y; Zhong A; Zhang C; Wei Z; Liu X; Dong S; Wu J; Xue Y; Wu M; Yao C
    Adv Healthc Mater; 2024 Mar; 13(7):e2302549. PubMed ID: 38059737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable hydrogels for the sustained delivery of a HER2-targeted antibody for preventing local relapse of HER2+ breast cancer after breast-conserving surgery.
    Chen X; Wang M; Yang X; Wang Y; Yu L; Sun J; Ding J
    Theranostics; 2019; 9(21):6080-6098. PubMed ID: 31534538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoadjuvants for cancer immunotherapy: A review of recent developments.
    Banstola A; Jeong JH; Yook S
    Acta Biomater; 2020 Sep; 114():16-30. PubMed ID: 32777293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutane Image-Guided Cryoablation of Painful Osseous Metastases: A Retrospective Single-Center Review.
    McArthur TA; Narducci CA; Lander PH; Lopez-Ben R
    Curr Probl Diagn Radiol; 2017; 46(4):282-287. PubMed ID: 28034477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Size selection of intrahepatic lesions for cryoablation contributes to abscopal effect and long-term survival in patients with liver metastatic melanoma receiving PD-1 blockade therapy.
    Shen L; Tan H; Nie J; Jiang Y; Nuerhashi G; Qi H; Cao F; Wen C; Chen S; Zhang T; Zheng W; Liu P; Liu Y; Huang T; Li D; Zhang X; Fan W
    Cancer Immunol Immunother; 2024 Mar; 73(4):68. PubMed ID: 38430269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryoablation and immune synergistic effect for lung cancer: A review.
    Tian Y; Qi X; Jiang X; Shang L; Xu K; Shao H
    Front Immunol; 2022; 13():950921. PubMed ID: 36389781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.